Strengthening Families & Communities, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1921196 BOSTON, MA

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$53,947

-$2,358 QoQ

Shares Held

427

+5.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#2,054

of 2,266 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Strengthening Families & Communities, LLC holds $15,119,704 across 12 Drug Manufacturers - General names. GILD ranks #5 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	21,481	$5,455,529
2	MRK	Merck & Co., Inc.	41,350	$5,313,475
3	LLY	ELI LILLY & Co	3,421	$4,103,250
4	AZN	Astrazeneca PLC	506	$95,947
5	GILD	Gilead Sciences, Inc. This page	427	$53,947
6	ABBV	AbbVie Inc.	176	$44,288
7	AMGN	Amgen Inc	75	$27,159
8	NVS	Novartis AG	100	$15,672

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$53,947	427	+5.7%	Shares	Sole	2026-08-11
2026-03-31	$56,305	404	-16.0%	Shares	Sole	2026-05-11
2025-09-30	$53,391	481	+20.6%	Shares	Sole	2025-11-04
2024-09-30	$33,452	399	-10.3%	Shares	Sole	2024-11-07
2024-06-30	$30,531	445	+22.9%	Shares	Sole	2024-07-22
2023-09-30	$27,128	362	+0.8%	Shares	Sole	2023-10-30
2023-06-30	$27,668	359	+17.7%	Shares	Sole	2023-07-26
2023-03-31	$25,305	305	+21.5%	Shares	Sole	2023-05-04
2022-12-31	$21,548	251	+0.8%	Shares	Sole	2023-02-06
2022-09-30	$15,360	249	-57.7%	Shares	Sole	2022-11-03
2022-06-30	$36,406	589	0.0%	Shares	Sole	2022-07-27
2022-03-31	$35,016	589	+0.5%	Shares	Sole	2022-05-12
2021-12-31	$42,549	586	—	Shares	Sole	2022-04-04
No filing history on record for this holder in this stock.